NCT05810909 is a NA clinical trial of amorphous calcium carbonate/ Placebo in Calcium, sponsored by Universal Integrated Corp..

Who is sponsoring NCT05810909?

NCT05810909 is sponsored by Universal Integrated Corp..

What drugs are being tested in NCT05810909?

Interventions in NCT05810909: amorphous calcium carbonate/ Placebo.

What condition does NCT05810909 study?

NCT05810909 studies Calcium, Osteopenia, Bone Mineral Density, Bone Turnover Marker.

Is NCT05810909 still recruiting?

NCT05810909 is currently completed. Last updated 13 April 2023.

Last reviewed 2023-04-13 · How we verify

NCT05810909

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Amorphous Calcium Carbonate Supplementation on Bone Health in Postmenopausal Women With Osteopenia

Completed NA Last updated 13 April 2023

What this trial tests

NA trial testing amorphous calcium carbonate/ Placebo in Calcium in 35 participants. Completed in 22 September 2022.

Timeline

10 December 2019

Primary endpoint
10 December 2021

22 September 2022

Quick facts

Lead sponsor	Universal Integrated Corp.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	35
Start date	10 December 2019
Primary completion	10 December 2021
Estimated completion	22 September 2022
Sites	1 location across Taiwan

Drugs / interventions tested

amorphous calcium carbonate/ Placebo

Conditions studied

Calcium — all drugs for Calcium →
Osteopenia — all drugs for Osteopenia →
Bone Mineral Density — all drugs for Bone Mineral Density →
Bone Turnover Marker — all drugs for Bone Turnover Marker →

Sponsor

Universal Integrated Corp. — full company profile →

Who can join

Eligibility, female only, with Calcium or Osteopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research was designed in accordance to the Method for Efficacy Assessment of Health Food for Bone Heath. Changes to bone density were measured to evaluate the effectiveness of amorphous calcium carbonate in maintaining bone health.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Calcium

Currently open trials in the same condition.

NCT06728462 — A Study of Amorphous Calcium Carbonate in Postmenopausal Women · NA · recruiting

Other Universal Integrated Corp. trials

Trials by the same sponsor.

NCT06728462 — A Study of Amorphous Calcium Carbonate in Postmenopausal Women · NA · recruiting
NCT03992365 — Study of the Efficacy and Safety of Quiklean® and Klean-Prep With Dulcolax® for the Bowel Preparation Prior to Colonosco · Phase 3 · completed
NCT01984008 — A Study of the Efficacy and Safety of Bowklean and Klean-Prep With Dulcolax for the Bowel Preparation Prior Colonoscopy · Phase 3 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05810909 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universal Integrated Corp.
Last refreshed: 13 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05810909.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing